Resiquimod topical gel 0.06%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Resiquimod topical gel 0.06%, covering 2016-06-22 to 2016-06-22. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Trial of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma [Phase 1, Phase 2]